Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Acceliant gets WHO...

    Acceliant gets WHO Drug Medical Coding Certification

    Written by supriya kashyap kashyap Published On 2017-02-12T10:25:55+05:30  |  Updated On 12 Feb 2017 10:25 AM IST
    Acceliant gets WHO Drug Medical Coding Certification

    Bangalore : Acceliant, the global leader in clinical trial management solutions, has announced that it has received the prestigious World Health Organization (WHO) Drug Dictionaries Medical Coding certification. The WHO Drug Dictionary is an international classification of medicines used by pharmaceutical companies, clinical trial organizations and drug regulatory authorities to identify drug names, active ingredients and their therapeutic use in spontaneous ADR reporting and in clinical trials.


    The WHO Drug-B2E certification makes Acceliant one of the few clinical trial solutions that meets the WHO criteria in providing accurate data through their coding engine. The certification further boosts Acceliant's eClinical Suite by enabling its clients to augment efficiency and productivity in the broad areas of clinical trials and new drug discoveries.


    The drug dictionary created by WHO Program for international drug monitoring is managed by the Uppsala Monitoring Centre, an independent foundation for scientific research based in Sweden. The center is authorized by the WHO to maintain the WHO Drug Medical Dictionaries.


    Vivek Gupta, Worldwide Vice President at Acceliant, said, "We are extremely pleased to receive the WHO Drug Medical Coding certificate for Acceliant clinical trials platform. Our medical coding module is well accepted and received greater appreciation from our clients because of its ability to accurately 'auto encode terms' and its flexibility to allow users to set threshold limits. The module supports different medical coding dictionaries. The WHO certification will tremendously expand Acceliant's credibility at the market place."


    Besides WHO Drug Dictionary, Acceliant also provides integrated coding mechanism, allowing users to code terms using MedDRA.

    AcceliantawardedMedical CodingMedical Coding CertificationVivek GuptaWHO DrugWorld Health Organization
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok